NYSE:MET - Metlife Stock Price, News, & Analysis

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be given a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.66%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife declared that its board has initiated a share repurchase plan on Tuesday, May 22nd 2018, which authorizes the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 3.1% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board of directors believes its stock is undervalued.

Metlife Inc (NYSE:MET) posted its earnings results on Wednesday, August, 1st. The financial services provider reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.17 by $0.13. The financial services provider earned $21.22 billion during the quarter, compared to analysts' expectations of $15.65 billion. Metlife had a return on equity of 9.17% and a net margin of 6.12%. The firm's revenue was up 36.8% on a year-over-year basis. During the same quarter last year, the business earned $1.04 earnings per share. View Metlife's Earnings History.

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Metlife.

15 brokers have issued twelve-month target prices for Metlife's shares. Their predictions range from $48.00 to $63.00. On average, they anticipate Metlife's stock price to reach $55.00 in the next twelve months. This suggests a possible upside of 19.7% from the stock's current price. View Analyst Price Targets for Metlife.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 8 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

Metlife saw a increase in short interest during the month of July. As of July 13th, there was short interest totalling 14,206,280 shares, an increase of 18.2% from the June 29th total of 12,020,301 shares. Based on an average daily volume of 4,474,570 shares, the days-to-cover ratio is currently 3.2 days. Currently, 1.6% of the shares of the company are sold short. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), AXA (AXAHY), Prudential Public (PUK), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Athene (ATH).

Media headlines about MET stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Metlife earned a coverage optimism score of 0.16 on Accern's scale. They also assigned news headlines about the financial services provider an impact score of 46.12 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View Recent Headlines for Metlife.

Metlife's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.11%), FMR LLC (4.60%), Massachusetts Financial Services Co. MA (2.41%), Bank of New York Mellon Corp (1.28%), Diamond Hill Capital Management Inc. (1.04%) and Epoch Investment Partners Inc. (0.87%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Epoch Investment Partners Inc., BlackRock Inc., Canada Pension Plan Investment Board, Bank of Montreal Can, Jennison Associates LLC, Caisse DE Depot ET Placement DU Quebec and United Services Automobile Association. View Insider Buying and Selling for Metlife.

MET stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Pzena Investment Management LLC, Morgan Stanley, Robeco Institutional Asset Management B.V., Putnam Investments LLC, Sumitomo Mitsui Trust Holdings Inc., LSV Asset Management and First Trust Advisors LP. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $45.94.

Metlife has a market capitalization of $44.42 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.